美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

基因编辑

377.54

+9.502.58%

涨家数：4

跌家数：1

平家数：- -

市盈率：- -

高：383.86

开：367.33

低：354.48

收：368.04

数据加载中...

Intellia Therapeutics, Inc.盘中异动急速拉升5.10%

Chardan Capital：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级,

Editas Medicine, Inc.盘中异动早盘快速下挫5.02%

Crispr Therapeutics Ag6月25日成交额为1.01亿美元

Editas Medicine, Inc.盘中异动临近午盘快速跳水5.18%报2.11美元

Editas Medicine, Inc.盘中异动早盘急速下跌5.53%报2.22美元

Editas Medicine, Inc.盘中异动早盘急速上涨5.61%

Editas Medicine, Inc.盘中异动早盘股价大涨5.08%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4556/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":377.5409,"timestamp":1751395616321,"preClose":368.03903,"halted":0,"volume":10524450,"delay":0,"changeRate":0.025818,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":9.501862,"latestTime":"07-01 14:46:56 EDT","open":367.33228,"high":383.86002,"low":354.47617,"amount":158890968.570672,"amplitude":0.079839,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1751400000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":1.922474,"peRate":-4.482417,"turnoverRate":0.01793,"increases":4,"decrements":1,"flats":0,"marketCap":7379643536,"floatMarketCap":7133006712},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":383.86002,"amplitude":0.079839,"preClose":368.03903,"low":354.47617,"pbRate":"1.922474","latestPrice":377.5409,"volume":10525218,"delay":0,"open":367.33228,"prevYearClose":376.62552,"prevWeekClose":363.1704,"prevMonthClose":368.039,"prevQuarterClose":368.039,"fiveDayClose":361.3764,"twentyDayClose":297.7491,"sixtyDayClose":277.284,"secType":"PLATE","market":"US","turnoverRate":0.017931,"peRate":-4.482417,"marketCap":7381371024,"floatMarketCap":7134725752,"timestamp":1751395618607,"nameCN":"基因编辑"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":4,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546422837","title":"Intellia Therapeutics, Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546422837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546422837?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 22:09","pubTimestamp":1751033374,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时09分，Intellia Therapeutics, Inc.股票出现异动，股价快速拉升5.10%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627220934a4c1696d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627220934a4c1696d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4588","BK4535","NTLA","BK4139","LU1861558580.USD","BK4556","LU1861559042.SGD","BK4539","BK4585"],"gpt_icon":0},{"id":"2546973288","title":"Chardan Capital：维持CRISPR Therapeutics(CRSP.US)评级，由买入调整至买入评级,","url":"https://stock-news.laohu8.com/highlight/detail?id=2546973288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546973288?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 22:47","pubTimestamp":1750949233,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4611","BK4556","BK4585","BK4007","BK4588","LU1861559042.SGD","CRSP","LU1861558580.USD","BK4539","LENZ"],"gpt_icon":0},{"id":"2546731049","title":"Editas Medicine, Inc.盘中异动 早盘快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546731049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546731049?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 22:12","pubTimestamp":1750947146,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日22时12分，Editas Medicine, Inc.股票出现异动，股价急速下挫5.02%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Vyne Therapeutics Inc.涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Vor Biopharma Inc.较为活跃，换手率分别为974.92%、219.17%、90.12%，振幅较大的相关个股有Vor Biopharma Inc.、Apollomics Inc C/Wts 01/04/2028 、Vyne Therapeutics Inc.，振幅分别为91.63%、40.05%、28.10%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626221226a4bf5852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626221226a4bf5852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2546275826","title":"Crispr Therapeutics Ag6月25日成交额为1.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546275826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546275826?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 09:40","pubTimestamp":1750902046,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Crispr Therapeutics Ag成交额为1.01亿美元，成交额较昨日减少12.27%，当日成交量为212.35万股。Crispr Therapeutics Ag于2025年6月25日涨1.88%，报47.66美元，该股过去5个交易日涨10.35%，年初至今涨21.09%，过去60日涨28.85%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094051a4be3deb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094051a4be3deb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4007","LU1861558580.USD","BK4588","CRSP","LENZ","BK4611","LU1861559042.SGD","BK4539","BK4585","BK4139"],"gpt_icon":0},{"id":"2545445295","title":"Editas Medicine, Inc.盘中异动 临近午盘快速跳水5.18%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545445295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545445295?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 00:00","pubTimestamp":1750694459,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时00分，Editas Medicine, Inc.股票出现异动，股价大幅下跌5.18%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为2592.25%、2039.94%、734.96%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为273.41%、79.75%、71.02%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062400010095283b76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062400010095283b76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2544317365","title":"Editas Medicine, Inc.盘中异动 早盘急速下跌5.53%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544317365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544317365?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 21:50","pubTimestamp":1750427427,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时50分，Editas Medicine, Inc.股票出现异动，股价大幅下挫5.53%。截至发稿，该股报2.22美元/股，成交量59.6287万股，换手率0.71%，振幅6.38%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620215027a4b4c639&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620215027a4b4c639&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2544290511","title":"Editas Medicine, Inc.盘中异动 早盘急速上涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544290511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544290511?lang=zh_cn&edition=fundamental","pubTime":"2025-06-18 22:09","pubTimestamp":1750255749,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日22时09分，Editas Medicine, Inc.股票出现异动，股价大幅拉升5.61%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Aptevo Therapeutics Inc.、Immatics N V C/Wts 01/07/2025 、Biodexa Pharmaceuticals Plc涨幅较大，Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃，换手率分别为7292.71%、815.91%、406.40%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Immatics N V C/Wts 01/07/2025 、Lixte Biotechnology Holdings, Inc.，振幅分别为122.70%、61.80%、42.34%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506182209099521ec62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506182209099521ec62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2543960638","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543960638","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543960638?lang=zh_cn&edition=fundamental","pubTime":"2025-06-16 22:24","pubTimestamp":1750083846,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日22时24分，Editas Medicine, Inc.股票出现波动，股价急速上涨5.08%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Sage Therapeutics, Inc.、Matinas Biopharma Holdings, Inc.、Nucana Plc涨幅较大，Nucana Plc、Processa Pharmaceuticals, Inc.、Matinas Biopharma Holdings, Inc.较为活跃，换手率分别为1923.87%、196.63%、58.75%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Matinas Biopharma Holdings, Inc.、Nextcure, Inc.，振幅分别为58.78%、41.67%、32.11%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162224069781fa0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506162224069781fa0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}